Central China Securities shares plunge in Shanghai and Hong Kong as asset management products face default risks
Shares of Central China Securities tumbled in Shanghai and Hong Kong after the brokerage said two of its asset-management products worth 241.5 million yuan (US$35.1 million) may be about to default on payments to investors.
The stock had slumped 9.8 per cent to 5.22 yuan at the close on Friday in Shanghai, capping its biggest decline since May 6. The shares lost 4 per cent to HK$1.70 in Hong Kong.
The two asset-management products were backed by Minxing Pharmaceutical, a drug maker in the northeast province of Fujian, according to the National Business Daily.
In an exchange filing, Central China Securities said it had spotted the risk that the fundraiser may default on payments, and then obtained evidence of falsified documents provided by the fundraiser.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
